DE602004004767T2 - Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern - Google Patents

Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern Download PDF

Info

Publication number
DE602004004767T2
DE602004004767T2 DE602004004767T DE602004004767T DE602004004767T2 DE 602004004767 T2 DE602004004767 T2 DE 602004004767T2 DE 602004004767 T DE602004004767 T DE 602004004767T DE 602004004767 T DE602004004767 T DE 602004004767T DE 602004004767 T2 DE602004004767 T2 DE 602004004767T2
Authority
DE
Germany
Prior art keywords
group
formula
alkyl group
oxo
pyridinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004004767T
Other languages
German (de)
English (en)
Other versions
DE602004004767D1 (de
Inventor
Jonathan Frost
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Publication of DE602004004767D1 publication Critical patent/DE602004004767D1/de
Application granted granted Critical
Publication of DE602004004767T2 publication Critical patent/DE602004004767T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE602004004767T 2003-03-07 2004-03-05 Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern Expired - Lifetime DE602004004767T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03290568A EP1454900A1 (en) 2003-03-07 2003-03-07 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto-esters
EP03290568 2003-03-07
PCT/EP2004/003052 WO2004078725A1 (en) 2003-03-07 2004-03-05 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto esters

Publications (2)

Publication Number Publication Date
DE602004004767D1 DE602004004767D1 (de) 2007-03-29
DE602004004767T2 true DE602004004767T2 (de) 2007-12-06

Family

ID=32799102

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004004767T Expired - Lifetime DE602004004767T2 (de) 2003-03-07 2004-03-05 Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern

Country Status (9)

Country Link
US (1) US7135569B2 (https=)
EP (2) EP1454900A1 (https=)
JP (1) JP4805809B2 (https=)
CN (1) CN100398518C (https=)
AT (1) ATE353877T1 (https=)
DE (1) DE602004004767T2 (https=)
ES (1) ES2281786T3 (https=)
RU (1) RU2330844C2 (https=)
WO (1) WO2004078725A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU556140A1 (ru) * 1975-01-06 1977-04-30 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвийской Сср (1-Оксоинданил-2)-пиридины в качестве промежуточных продуктов дл синтеза биологически активных соединений с способ их получени
US6300511B1 (en) * 1997-07-18 2001-10-09 F2 Chemicals Limited Catalyzed fluorination of carbonyl compounds
US6455728B1 (en) * 1999-11-01 2002-09-24 Air Products And Chemicals, Inc. Direct fluorination process for preparing high purity 2-fluoro-1,3-dicarbonyl compounds using oxygen as a radical scavenger
EP1295885A1 (en) * 2001-09-21 2003-03-26 Sanofi-Synthelabo Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives
AU2002350487C1 (en) * 2001-09-21 2008-10-02 Mitsubishi Pharma Corporation Substituted 2-pyridinyl-6,7,8,9- tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives
EP1295884A1 (en) * 2001-09-21 2003-03-26 Sanofi-Synthelabo 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 7-Pyrimidinyl-2,3-Dihydroimidazo[1,2-a]Pyrimidin-5(1H)one derivatives

Also Published As

Publication number Publication date
ES2281786T3 (es) 2007-10-01
JP2006519815A (ja) 2006-08-31
EP1454900A1 (en) 2004-09-08
DE602004004767D1 (de) 2007-03-29
US7135569B2 (en) 2006-11-14
EP1603876A1 (en) 2005-12-14
RU2005131007A (ru) 2006-06-27
CN1771229A (zh) 2006-05-10
EP1603876B1 (en) 2007-02-14
RU2330844C2 (ru) 2008-08-10
ATE353877T1 (de) 2007-03-15
CN100398518C (zh) 2008-07-02
JP4805809B2 (ja) 2011-11-02
US20060058526A1 (en) 2006-03-16
WO2004078725A1 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
DE602004004767T2 (de) Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern
EP0200051B1 (de) Verfahren zur Herstellung von Imidaten
EP0370391B1 (de) Verfahren zur Herstellung von 4,5-Dichlor-6-ethylpyrimidin
DE3132332C2 (https=)
DE3102516A1 (de) Verfahren zur herstellung von optisch aktiven 2-chlorpropionsaeureestern
DE69309935T2 (de) Verfahren für die synthese von 2,6-dichlor-5-fluornicotinsäure und 2,6-dichlor-5-fluornicotinoylchlorid
EP0470462A2 (de) Verfahren zur Herstellung von Halogenmethylketonen, insbesondere von 1,1,1-Trifluoraceton
EP0216324B1 (de) 4-Alkoxy-3-pyrrolin-2-on-1-yl-essigsäurealkyl- bzw. -benzylester sowie deren Herstellung
CH638497A5 (de) Verfahren zur herstellung von 2,3,5-trichlorpyridin.
DE60004850T2 (de) Verfahren zur herstellung von (r) und (s)-aminocarnitin und deren derivative aus d- und l-aspargin säure
EP0378089B1 (de) Verfahren zur Herstellung von 2-Amino-4-fluorpyrimidinderivaten
CH645623A5 (en) 2-Methyl-3-acetoxy-4,5-bis(halomethyl)pyridines, process for their preparation and process for the preparation of pyridoxin
DE4408083C1 (de) Verfahren zur Herstellung von 4-Fluoralkoxyzimtsäurenitrilen
EP0252515A1 (de) Vefahren zur Herstellung von 6-(Amino)-1,2-di-(hydro)-1-(hydroxy)-2-(imino)-4-(piperidino)-pyrimidin
EP3548463B1 (de) Verfahren zur herstellung von 3-substituierten 2-vinylphenylsulfonaten
EP1671939A1 (de) Verfahren zur Herstellung von enantiomerenangereicherten 2-Fluorcarbonsäureestern
EP1019356A2 (de) Verfahren zur herstellung von 3-hydroxy-2-methylbenzoesäure
WO2003022818A1 (de) Verfahren zur herstellung von 4-haloalkylnicotinsäureestern
DE19713506A1 (de) Verfahren zur Herstellung von 2,6-Dichlor-5-fluornicotinonitril und die chemische Verbindung 3-Cyano-2-hydroxy-5-fluorpyrid-6-on-mononatriumsalz sowie dessen Tautomere
AT500971A1 (de) Verfahren zur herstellung von 2,2-dimethyl-3- (1-propenyl)cyclopropancarboxylatester
DE2329251C2 (de) Verfahren zur Herstellung von disubstituiertem Malonsäuredinitril
DE2352706A1 (de) Verfahren zur herstellung von isonitrosomalonsaeureestern
DE2341214B2 (de) Verfahren zur herstellung von 2,4- diamino-5-benzyl-pyrimidinen
EP0633249B1 (de) Verfahren zur Herstellung von 2,4-Pyridindicarbonsäure
DE2023429A1 (de) Verfahren zur Herstellung von Dialkylformamid-Derivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition